Amicus' Crowley on Expanding Pipeline for Rare Diseases (Audio)

Jul 18, 2016 · 8 min · 7.7 MB

0:00-8:00

Streams straight from the publisher. podnod never proxies or re-hosts episode audio.

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.

See omnystudio.com/listener for privacy information.